[Research Report] The male infertility market is expected to reach US$ 6,213.96 million by 2027 from US$ 3,883.82 million in 2019; it is estimated to grow at a CAGR of 6.2% from 2020 to 2027.
Factors such as increase in male infertility worldwide and technological advancements drive the market growth. However, the high cost of procedures hinders the male infertility market growth.
Lucrative Regional Markets for Male Infertility
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Market Insights
Increase in Male Fertility Worldwide
Infertility in males is a global issue with prevalence percentages varying from one region to another. Deficiencies in semen and poor semen quality are the prime causes of infertility in men. According to the National Institutes of Health (NIH), infertility affected ~15% couples, i.e., ~48.5 million couples, worldwide in 2016. Further, according to a research survey published in the Journal of Reproductive Biology and Endocrinology, in 2016, infertility rate among men was found to be highest in Africa and Eastern/Central Europe. According to the World Health Organization (WHO), among ~20% of infertile couples, the problem is with male partners, whereas in 30% of couples, the issue exists in both the partners. Thus, men contribute to ~50% of the infertility cases globally. Furthermore, according to Healthy Male Andrology Australia, a division funded by Australian Government Department of Health, ~1 in 20 males produces low number of sperms, leading to infertility, and 1 in ~100 men has no sperms at all.
A few of the common factors responsible for causing infertility in men include low hormone production levels in pituitary gland, sexual problems affecting the entry of semen into vaginal tract, and presence of sperm antibodies. Varicocele, i.e., a presence of enlarged veins in testicle, is the most common cause of low sperm count in men. According to the US Department of Health and Human Services, varicocele is present in ~40% of men suffering from infertility problems.
Thus, the staggering prevalence of male infertility is generating greater demands for male infertility treatments and services.
Test-BasedInsights
The global male infertility market, based on test, is segmented into DNA fragmentation technique, oxidative stress analysis, computer assisted semen analysis, microscopic examination, sperm agglutination, sperm penetration assay, and others. The DNA fragmentation technique segment held the largest share of the market in 2019; whereas the computer assisted semen analysis segment is anticipated to register the highest CAGR in the market during the forecast period.
Global Male Infertility Market, by Test – 2019 and 2027
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
- Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
Treatment Type-Based Insights
The male infertility market, based on treatment type, is segmented into assisted reproductive technology and varicocele surgery, and medication. The assisted reproductive technology and varicocele surgery segment held a larger share of the market in 2019 and is anticipated to register a higher CAGR in the market during the forecast period.
Distribution Channel-Based Insights
The male infertility market, based on distribution channel, is segmented into hospitals pharmacies, pharmacies and drug stores, and online pharmacies. In 2019, the hospitals pharmacies segment held the largest share of the market. Moreover, the market for the same segment is estimated to grow at the highest CAGR during 2020–2027.
End User-Based Insights
The male Infertility market, based on end user, is segmented into fertility centers, hospitals and clinics, research institutes, and other end users. In 2019, the fertility centers segment held the largest share of the market. Moreover, the same segment is anticipated to register the highest CAGR of 6.8% in the market from 2020 to 2027.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Male Infertility Market: Strategic Insights
Market Size Value in US$ 3,883.82 Million in 2019 Market Size Value by US$ 6,213.96 Million by 2027 Growth rate CAGR of 6.2% from 2020-2027 Forecast Period 2020-2027 Base Year 2020
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Male Infertility Market: Strategic Insights
Market Size Value in | US$ 3,883.82 Million in 2019 |
Market Size Value by | US$ 6,213.96 Million by 2027 |
Growth rate | CAGR of 6.2% from 2020-2027 |
Forecast Period | 2020-2027 |
Base Year | 2020 |
Akshay
Have a question?
Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to AnalystCompanies such as Vitrolife and Halotech DNA have adopted several inorganic and organic strategies to enhance their revenue and position in the male infertility market. The involved performances of major players have resulted in the availability of better services and products in the market.
Male Infertility Market – by Test
- DNA Fragmentation Technique
- Oxidative Stress Analysis
- Microscopic Examination
- Sperm Agglutination
- Computer Assisted Semen Analysis
- Sperm Penetration Assay
- Others
Male Infertility Market – by Treatment Type
- Assisted Reproductive Technology
- In-Vitro Fertilization (IVF)
- Intracytoplasmic Sperm Injection (ICSI)
- Varicocele Surgery
- Medication
Male Infertility Market – by Distribution Channel
- Hospitals Pharmacies
- Pharmacies and Drug Stores
- Online Pharmacies
Male Infertility Market – by End User
- Hospitals and Clinics
- Fertility Centers
- Research Institutes
- Other End Users
Male Infertility Market – by Geography
North America
- US
- Canada
- Mexico
Europe
- Germany
- UK
- France
- Italy
- Spain
- Sweden
- Denmark
- Poland
- Turkey
- The Netherlands
- Belgium
- Finland
- Switzerland
- Ireland
- Norway
- Rest of Europe
Asia Pacific (APAC)
- Japan
- China
- India
- South Korea
- Australia
- Thailand
- Singapore
- New Zealand
- Vietnam
- Rest of Asia Pacific
Middle East and Africa (MEA)
- UAE
- Saudi Arabia
- South Africa
- Egypt
- Israel
- Rest of Middle East and Africa
South and Central America (SCAM)
- Brazil
- Argentina
- Rest of South and Central America
Company Profiles
- MERCK KGaA
- Sanofi
- Bayer AG
- Endo Pharmaceuticals Inc.
- SCSA Diagnostics, Inc.
- Andrology Solutions
- Halotech DNA
- INTAS PHARMACEUTICALS LTD.
- Cadila Pharmaceuticals Ltd.
- Vitrolife
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Test ; Treatment Type ; Distribution Channel ; End User , and Geography
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Belgium, Brazil, Canada, China, Denmark, Egypt, Finland, France, Germany, India, Ireland, Israel, Italy, Japan, Mexico, Netherlands, New Zealand, Norway, Poland, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, United Arab Emirates, United Kingdom, United States, Vietnam
Frequently Asked Questions
Male infertility is due to low sperm production, abnormal sperm function or blockages that prevent the delivery of sperm. Illnesses, injuries, chronic health problems, lifestyle choices such as Smoking, drinking alcohol, and taking certain medications can lower sperm numbers. Other causes of low sperm numbers include long-term sickness (such as kidney failure), childhood infections (such as mumps), and chromosome or hormone problems (such as low testosterone). In over a third of infertility cases, the problem is with the man. This is most often due to problems with the sperm production or with sperm delivery.
The male infertility market is estimated to grow owing to key driving factors such as increasing infertility rate, rising adoption of assisted reproductive technologies (ART), and a shift towards sedentary lifestyle across the globe. However, high cost of the procedures is likely to hamper the growth of the market during the forecast period.
Global male infertility market is segmented by region into North America, Europe, Asia-Pacific, Middle East & Africa and South & Central America. In North America, the U.S. holds a significant share of the male infertility market. Innovations in the product line primarily drive the growth of the market in the country. The country focuses on changing the overall landscape and the best in the class healthcare infrastructure, advanced facilities, and awareness and openness amongst citizens towards the disease.The increasing infertility rate in the country is the primary factor driving growth during the study period. For instance, Infertility is a common problem, with more than 5 million couples in the United States dealing with these problems. It affects one in every six couples who are trying to conceive. In at least half of all cases of Infertility, a malefactor is a primary or contributing cause. This means that about 10% of all men in the United States attempting to conceive suffer from Infertility.
The List of Companies - Male Infertility Market
- MERCK KGaA
- Sanofi
- Bayer AG
- Endo Pharmaceuticals Inc.
- SCSA Diagnostics, Inc.
- Andrology Solutions
- Halotech DNA
- INTAS PHARMACEUTICALS LTD.
- Cadila Pharmaceuticals Ltd.
- Vitrolife.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Male Infertility Market
Oct 2020
Bioprocessing Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Instruments, and Consumables and Accessories), Scale of Operation (Commercial Operations and Clinical Operations), Process (Downstream Bioprocess and Upstream Bioprocess), Application (Monoclonal Antibodies, Vaccines, Recombinant Protein, Cell and Gene Therapy, and Others), End User (Biopharmaceutical Companies, Contract Manufacturing Organization, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2020
Bioproduction Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product (Biologics and Biosimilars, Vaccines, Cell and Gene Therapies, Nucleic Acid Therapeutics, and Others), Application (Rheumatoid Arthritis, Hematological Disorders, Cancer, Diabetes, Cardiovascular Diseases, and Others), Equipment (Upstream Equipment, Downstream Equipment, Bioreactors, and Consumables and Accessories), End User (Biopharmaceutical Companies, Contract Manufacturing Organizations, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Oct 2020
ELISA Diagnostic Test Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Adoption (Human and Veterinary), Test Type (Sandwich ELISA, Indirect ELISA, Competitive ELISA, and Multiple & Portable ELISA), Application (Autoimmune Diseases, Infectious Diseases, Cancer Diagnosis, Protein Quantification, and Others), End User (Hospitals & Diagnostic Centers, Pharmaceutical & Biotechnology Companies, Veterinary Hospitals & Diagnostic Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, South & Central America, and Middle East & Africa)
Oct 2020
Swine Diagnostics Market
Size and Forecasts (2022 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type [Immunoassays Kits, PCR Kits, Hemagglutination Inhibition (HI), and Others], Sample Type (Blood, Oral Fluids, Nasal Swabs, Tissue Samples, and Others), Disease [African Swine Fever (ASF)/Classical Swine Fever (CSF), Respiratory Diseases, Porcine Circovirus, Porcine Epidemic Diarrhea, Swine Dysentery, and Others], End User (Veterinary Hospitals, Veterinary Clinics, and Other End Users), and Geography
Oct 2020
Microbial Identification Methods Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Method (Genotypic, Phenotypic, and Proteotypic), Type (Bacterial Identification System, Microbial Enumeration System, Bacterial Resistance Identification Systems, Microbiology Analyzer, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and Latin America)
Oct 2020
Biopharmaceuticals Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Monoclonal Antibodies, Recombinant Vaccines, Conventional Vaccines, Recombinant Growth Factors, Purified Proteins, Recombinant Proteins, Recombinant Hormones, Recombinant Enzymes, Cell & Gene Therapies, Cytokines/Interferon/Interleukins, and Others) and Application (Oncology, Inflammatory & Infectious Disease, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders & Growth Failure, Cardiovascular Diseases, Neurological Diseases, and Others)
Oct 2020
GMP Cell Therapy Consumables Market
Forecast to 2028 - COVID-19 Impact and Global Analysis by Product (Kits, Reagents/Molecular Biology Reagents, Growth Factors/Cytokines and Interleukins, and Others), Cell Therapy (NK Cell Therapy, Stem Cell Therapy, T-Cell Therapy, and Others), Process (Cell Collection and Characterization/Sorting and Separation, Cell Culture and Expansion/Preparation, Cryopreservation, Cell Processing and Formulation, Cell Isolation and Activation, Cell Distribution/Handling, Process Monitoring and Control/Readministration/Quality Assurance, and Others), and End Use (Clinical, Commercial, and Research)
Oct 2020